Occult Hepatitis B Virus (HBV) Infection: a Global Challenge for Medicine

被引:20
|
作者
Assar, Shokrollah [1 ]
Arababadi, Mohammad Kazemi [1 ]
Ahmadabadi, Behzad Nasiri [1 ]
Salehi, Mansoor [2 ]
Kennedy, Derek [3 ]
机构
[1] Rafsanjan Univ Med Sci, Immunol Infect Dis Res Ctr, Rafsanjan, Iran
[2] Isfahan Univ Med Sci, Fac Med, Dept Genet, Esfahan, Iran
[3] Griffith Univ, Sch Biomol & Phys Sci, Eskitis Inst Cell & Mol Therapies, Nathan, Qld 4111, Australia
关键词
Occult HBV infection; blood donors; post transfusion hepatitis; BLOOD-DONORS; ANTI-HBC; HEMODIALYSIS-PATIENTS; DNA; GENOTYPE; IRAN; RISK;
D O I
10.7754/Clin.Lab.2012.120119
中图分类号
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号
1001 ;
摘要
Hepatitis B virus (HBV) is a serious risk as a disease that can be spread through blood transfusion. Occult hepatitis B infection (OBI) is defined in a patient with the presence of HBV-DNA but a lack of HBsAg in the serum and hepatocytes. OBI can be considered as a high potential risk factor for inducing post transfusion hepatitis (PTH), hepatocellular carcinoma (HCC), cirrhosis, and reactivation of the HBV. Recently, several investigations from various regions of the world have reported PTH as well as HCC and cirrhosis among blood recipients with diseases such as thalassemia and other disorders requiring regular hemodialysis. This form of hepatitis also causes complications for individuals that are co-infected with other viruses such as HCV and HIV. Because of its extreme disease potential, OBI can be considered a high risk for PTH, HCC, and cirrhosis. Therefore, an understanding of the prevalence of OBI among blood donors is a critical strategy in most transfusion services. This review addresses the recent information regarding the prevalence of OBI worldwide, with an additional focus on Iranian blood donors. (Clin. Lab. 2012;58:1225-1230. DOI: 10.7754/Clin.Lab.2012.120119)
引用
收藏
页码:1225 / 1230
页数:6
相关论文
共 50 条
  • [31] Occult Hepatitis B Virus Infection: An Update
    Saitta, Carlo
    Pollicino, Teresa
    Raimondo, Giovanni
    VIRUSES-BASEL, 2022, 14 (07):
  • [32] Update on occult hepatitis B virus infection
    Manoochehr Makvandi
    World Journal of Gastroenterology, 2016, (39) : 8720 - 8734
  • [33] Silent (occult) hepatitis B virus infection
    Uchida, T
    JOURNAL OF PATHOLOGY, 2000, 190 : 28A - 28A
  • [34] An overview of occult hepatitis B virus infection
    Zeinab Nabil Ahmed Said
    World Journal of Gastroenterology, 2011, 17 (15) : 1927 - 1938
  • [35] Occult hepatitis B virus infection and transfusion
    Allain, JP
    JOURNAL OF HEPATOLOGY, 2006, 44 (03) : 617 - 618
  • [36] Update on occult hepatitis B virus infection
    Makvandi, Manoochehr
    WORLD JOURNAL OF GASTROENTEROLOGY, 2016, 22 (39) : 8720 - 8734
  • [37] Occult hepatitis B virus infection in Egypt
    Elbahrawy, Ashraf
    Alaboudy, Alshimaa
    El Moghazy, Walid
    Elwassief, Ahmed
    Alashker, Ahmed
    Abdallah, Abdallah Mahmoud
    WORLD JOURNAL OF HEPATOLOGY, 2015, 7 (12) : 1671 - 1678
  • [38] An overview of occult hepatitis B virus infection
    Said, Zeinab Nabil Ahmed
    WORLD JOURNAL OF GASTROENTEROLOGY, 2011, 17 (15) : 1927 - 1938
  • [39] Control of occult hepatitis B virus infection
    Garces, Marta Lalana
    Pastor, Oihana Ortiz
    Enrech, Gemma Sole
    Guerra-Ruiz, Armando R. R.
    Mercadal, Gregori Casals
    Lafuente, Alejandro Almeria
    Vizoso, Maria Antonieta Ballesteros
    Medina, Pablo Gabriel
    Fernandez, Sergio Salgueero
    Trillo, Angielys Zamora
    de la Serna, Isabel Aured
    Hurtado, Juan Carlos
    Perez-Del-Pulgar, Sofia
    Forns, Xavier
    Ruiz, Manuel Morales
    ADVANCES IN LABORATORY MEDICINE-AVANCES EN MEDICINA DE LABORATORIO, 2022, 3 (04): : 321 - 330
  • [40] Occult hepatitis B virus (HBV) infections: Hepatitis B surface antigen (HBsAg) negative and primary occult
    Bonino F.
    Brunetto M.R.
    Current Hepatitis Reports, 2013, 12 (2) : 112 - 118